Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment is a research paper published in Molecular Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 172 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDCR NIH HHS
Grant: R01 DE028420
NCI NIH HHS
Grant: P50 CA261605
National Cancer Institute
Merck KGaA
EMD Serono
GlaxoSmithKline
National Institutes of Health
FWCI
7.70
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals